Answer
Whether tocilizumab passes into human milk is unknown, and animal milk excretion has not been studied; the decision to discontinue breast-feeding or discontinue/abstain from RoActemra therapy must weigh breast-feeding benefits for the child against treatment benefits for the woman.
Sources for this answer
- RoActemra 20mg/ml Concentrate for Solution for InfusionRoche Products Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 38Document updated
Sources checked